Skip to search formSkip to main contentSkip to account menu

Estratab

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Estradiol CongenersEstrogens, Esterified (USP)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Influence of hormone therapy on the cardiovascular responses to stress of postmenopausal women
2001
2001
Low‐Dosage Esterified Estrogens Opposed by Progestin at 6‐Month Intervals
Highly Cited
1997
Highly Cited
1997
Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab/Osteoporosis Study Group.
BACKGROUND Prospective studies have shown that doses equivalent to conjugated equine estrogens of 0.625 mg/d or higher are needed… 
1996
1996
Low Incidence of Endometrial Hyperplasia and Bleeding in Women on 2 Yrs of Unopposed 0.3 Mg Esterified Estrogens (ESTRATAB®): P-17.
1996
1996
Reduction in Menopausal Symptoms Following 0.3 Mg ESTRATAB® Administration Compared to Higher Doses and Placebo: P-18.
1994
1994
Differences in pharmacokinetics and comparative bioavailability between premarin® and estratab® in healthy postmenopausal women
1993
1993
Estratab, Estratest, and Premarin are not bioequivalent.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)